Recent advances in the design of small molecular drugs with acrylamides covalent warheads

被引:2
|
作者
Liang, Luxia [1 ,2 ,3 ]
Zhang, Ze [1 ,2 ,3 ]
You, Qidong [1 ,2 ,3 ]
Guo, Xiaoke [1 ,2 ,3 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China
[3] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing 210009, Peoples R China
基金
中国国家自然科学基金;
关键词
Acrylamide; Covalent warhead; Small molecular drug; Inhibitors; GROWTH-FACTOR RECEPTOR; BRUTONS TYROSINE KINASE; IRREVERSIBLE INHIBITORS; JAK3; INHIBITORS; DISCOVERY; CANCER; INACTIVATION; QUINAZOLINE; REACTIVITY; STRATEGY;
D O I
10.1016/j.bmc.2024.117902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the development of covalent inhibitors, acrylamides warhead is one of the most popular classes of covalent warheads. In recent years, researchers have made different structural modifications to acrylamides warheads, resulting in the creation of fluorinated acrylamide warheads and cyano acrylamide warheads. These new warheads exhibit superior selectivity, intracellular accumulation, and pharmacokinetic properties. Additionally, although ketoamide warheads have been applied in the design of covalent inhibitors for viral proteins, it has not received sufficient attention. Combined with the studies in kinase inhibitors and antiviral drugs, this review presents the structural features and the progression of acrylamides warheads, offering a perspective on future research and development in this field.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Recent Advances in Synthetic Drugs and Natural Actives Interacting with OAT3
    Chen, Ying
    Li, Hongyan
    Wang, Ke
    Wang, Yousheng
    MOLECULES, 2023, 28 (12):
  • [42] Label-free target protein characterization for small molecule drugs: recent advances in methods and applications
    Feng, Fei
    Zhang, Weiyue
    Chai, Yifeng
    Guo, Dandan
    Chen, Xiaofei
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 223
  • [43] Recent advances in oncolytic virus design
    Hernandez-Alcoceba, Ruben
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (04) : 229 - 239
  • [44] Recent advances in oncolytic virus design
    Rubén Hernández-Alcoceba
    Clinical and Translational Oncology, 2011, 13 : 229 - 239
  • [45] Recent Advances of p53-MDM2 Small Molecule Inhibitors (2011-Present)
    Lv, Peng-Cheng
    Sun, Juan
    Zhu, Hai-Liang
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (05) : 618 - 626
  • [46] Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials
    Manetti, Fabrizio
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 445 - 458
  • [47] Design, synthesis, and biological evaluation of quinazoline derivatives with covalent reversible warheads as potential FGFR4 inhibitors
    Nie, Wenwen
    Lu, Yang
    Pan, Chenghao
    Gao, Jian
    Luo, Mengxin
    Du, Jiaming
    Wang, Jiao
    Luo, Peihua
    Zhu, Hong
    Che, Jinxin
    He, Qiaojun
    Dong, Xiaowu
    BIOORGANIC CHEMISTRY, 2022, 121
  • [48] Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease
    Lipinski, Piotr F. J.
    Zaborniak, Jolanta
    Garnuszek, Piotr
    Szurmak, Przemyslaw
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (03) : 838 - 842
  • [49] Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV)
    Bano, Sehrish
    Hameed, Abdul
    Al-Rashida, Mariya
    Iflikhar, Shafia
    Iqbal, Jamshed
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (22) : 4484 - 4498
  • [50] Recent Advances in Computer-Assisted Structure-Based Identification and Design of Histone Deacetylases Inhibitors
    Krishna, Shagun
    Kumar, Vikash
    Siddiqi, Mohammad Imran
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (09) : 934 - 947